The best-studied biological age test — the epigenetic, or DNA methylation, "clock" — does one thing with real, published accuracy: it estimates a person's age from a blood or tissue sample closely enough that researchers use it as a standard measure in aging research. Whether it can also tell one specific person how fast their body is aging, which is the result most commercial tests are sold on, is a separate question the scientists who built these clocks say is still open.
In brief:
- The original DNA methylation clock, built in 2013 from 8,000 samples across 51 human tissue and cell types, closely tracks a person's actual age.
- A 2015 study of four cohorts of older adults found that people whose methylation age ran 5 years ahead of their real age had a 21% higher risk of dying over the following years than people whose clock matched their age.
- The researchers who build and study these clocks — in a 2019 review co-authored by the scientist who created the original one — say that using them to tell one individual their own personal aging rate, the use case behind most consumer results, remains a key open research challenge.
What is a biological age test, actually?
Most of what's marketed as a "biological age test" today is some version of an epigenetic clock. The idea: DNA methylation, a chemical modification that turns genes up or down without changing the underlying sequence, shifts at specific locations on the genome in a pattern that tracks age closely enough to be measured. In 2013, the researcher who built the most widely used version trained a predictor on 8,000 samples from 82 methylation datasets, covering 51 healthy human tissue and cell types, using the methylation levels at 353 specific sites. The result tracked actual age closely across almost every tissue tested, read close to zero in embryonic and induced pluripotent stem cells, and even worked on chimpanzee tissue — evidence that it's measuring a real, conserved biological process, not a quirk of one dataset.
Other approaches exist too — tests built from blood chemistry panels, or from markers other than methylation — but the DNA methylation clock is the most studied version and the basis for most of what gets sold as a "biological age" number today.
Does the test measure anything beyond your birth certificate?
This is the real question behind "do they work." A clock that only reproduces your actual age would be an expensive calendar. The more interesting claim is that the gap between your methylation age and your real age — running a few years "older" or "younger" than your birthday says — means something on its own.
That gap does appear to carry real information, at least in a population. A 2015 study followed four separate cohorts of older adults and found that a 5-year higher gap between methylation age and chronological age was associated with a 21% higher risk of dying over the study's follow-up, after adjusting for age and sex. The association held up, at a reduced but still meaningful 16% higher risk, even after accounting for childhood IQ, education, social class, hypertension, diabetes, cardiovascular disease, and a major genetic risk variant (APOE e4) — factors that might otherwise explain away the link.
That's a real, attributed, peer-reviewed finding. It's also a population-level association in longitudinal cohorts of older adults, not a finding about what any one person's own 5-year gap means for their own future, and an association between two measurements is not proof that the clock is capturing a cause of aging rather than something that simply moves alongside it.
What the research says
The clock's accuracy as an age-predictor is well established: the original 2013 paper showed it tracking chronological age closely across dozens of tissue types, and the gap between predicted and actual age was shown in the 2015 study to associate with mortality risk in a way that survived adjustment for several major known risk factors.
What's less settled is how to use that gap for one individual. A 2019 consensus review — co-authored by researchers across the field, including the scientist who built the original clock — describes epigenetic clocks as "a highly accurate molecular correlate of chronological age," and notes that extensive, ongoing research is aimed at using them to measure biological aging rates and test whether a specific intervention slows or reverses aging. The same review says understanding what actually drives the clock, and what the differences between one person's result and another's really mean, remains a key open challenge — and it raises real ethical questions around predicting one specific person's own aging trajectory from a single test. In other words, the field's own leading researchers treat "can this tell you, personally, how fast you're aging, and whether something you did changed it" as an unresolved research question, not a settled clinical use.
Can a biological age test tell you how to slow aging?
Not on its own, and not yet reliably for any one person — at least according to the people who built it. The clock is a measurement, not a treatment plan: no study referenced here tested whether acting on a specific biological-age number changes how fast someone actually ages. The 2015 mortality finding is about the gap predicting risk in groups of people who were simply measured once, not about what happens when someone intervenes and gets re-tested.
What you can do this week
- Ask what a result is validated against, not just the brand name. A published 21%-higher-mortality finding is specific to how one particular lab built and tested its clock in specific cohorts; a number from a different formula doesn't automatically carry that same track record.
- Weigh a biological-age number against measures your clinician already knows how to act on. Blood pressure, blood sugar, and cholesterol are measured with far more precision, have decades of outcome data behind specific numbers, and come with an established next step — a single age-estimate score currently doesn't.
- Treat the result as a research data point, not a verdict. The scientists who build these clocks say, in their own words, that using one to measure whether a habit, product, or treatment is "working" on you personally is still an active research question — a useful thing to discuss with a clinician, not a number to act on by itself.








